. 2010 Mar 12;85(11):100-7.

Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010

[Article in English, French]

No authors listed

Free article

[Article in English, French]

No authors listed. Wkly Epidemiol Rec. 2010.

Free article

. 2010 Mar 12;85(11):100-7.

No abstract available

Cited by

Enhanced Downstream Processing for a Cell-Based Avian Influenza (H5N1) Vaccine.
Li F, Liu B, Xiong Y, Zhang Z, Zhang Q, Qiu R, Peng F, Nian X, Wu D, Li X, Liu J, Li Z, Tu H, Wu W, Wang Y, Zhang J, Yang X. Li F, et al. Vaccines (Basel). 2024 Jan 29;12(2):138. doi: 10.3390/vaccines12020138. Vaccines (Basel). 2024. PMID: 38400122 Free PMC article.
An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.
Zhao G, Sun S, Du L, Xiao W, Ru Z, Kou Z, Guo Y, Yu H, Jiang S, Lone Y, Zheng BJ, Zhou Y. Zhao G, et al. Virol J. 2010 Jul 12;7:151. doi: 10.1186/1743-422X-7-151. Virol J. 2010. PMID: 20624292 Free PMC article.
Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.
Lekcharoensuk P, Wiriyarat W, Petcharat N, Lekcharoensuk C, Auewarakul P, Richt JA. Lekcharoensuk P, et al. Vaccine. 2012 Feb 14;30(8):1453-9. doi: 10.1016/j.vaccine.2011.12.109. Epub 2012 Jan 9. Vaccine. 2012. PMID: 22230579 Free PMC article.